Podcast Episodes

Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.

We love to hear from our listeners. Send us a message.

Is it past time for a new approach to the COVID vaccine? Ocugen Chairman of the Board, Founder…

3 years, 2 months ago

View Episode

Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed

We love to hear from our listeners. Send us a message.

Call it fortuitous, good planning, instinct, or a combination of all three, but Nadim Ahmed's …

3 years, 2 months ago

View Episode

Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.

We love to hear from our listeners. Send us a message.

After more than 21 years leading process, product, and technical development efforts at Merck …

3 years, 3 months ago

View Episode

Computational Drug Discovery With Gain Therapeutics' Matthias Alder

We love to hear from our listeners. Send us a message.

Gain Therapeutics' newly-appointed CEO Matthias Alder offers up a deep, yet abundantly clear e…

3 years, 3 months ago

View Episode

Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany

We love to hear from our listeners. Send us a message.

Join Matt Pillar for a conversation with Carine Boustany, PharmD and SVP, US Research Site Hea…

3 years, 3 months ago

View Episode

AI & Computational Biology With Recursion's Chris Gibson, Ph.D.

We love to hear from our listeners. Send us a message.

Recursion's unique, technology-aided approach to drug discovery has yielded one of the deepest…

3 years, 3 months ago

View Episode

Allan Shaw On Financing Biopharma Innovation

We love to hear from our listeners. Send us a message.

Friend and frequent guest Allan Shaw rejoins the Business of Biotech to reflect on his recent …

3 years, 4 months ago

View Episode

Gene Therapy For Chronic Inflammation With Xalud's Howard Rutman, M.D.

We love to hear from our listeners. Send us a message.

While many gene therapy development efforts focus on rare disease, Xalud Therapeutics is takin…

3 years, 4 months ago

View Episode

The Antibody Engine With Abpro's Chan Brothers

We love to hear from our listeners. Send us a message.

In an industry that takes new business naming conventions to extremes, Abpro is a refreshingly…

3 years, 4 months ago

View Episode

In-Vivo CAR T Update With Umoja Biopharma's David Fontana, Ph.D.

We love to hear from our listeners. Send us a message.

2023 is just around the corner, and it's shaping up to be a big year for Umoja Biopharma. The …

3 years, 4 months ago

View Episode